<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20100717004399N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-06-29</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effect of spiritual intelligence training on the mental health of the elderly</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of spiritual intelligence training on the mental health of the elderly living in the nursing home centers of Shiraz</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-06-15</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/70501</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Other design features: In this study, one of the clusters, which are the centers, will be the intervention group and the other will be the control group.A total of 60 people, Randomization description: Sampling will be in the form of random clusters. Clusters are care centers for the elderly. Two centers are randomly selected from among all centers. In the next stage, one of these two centers will be selected by lottery as the intervention group and the other will be the control group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: obsessive compulsive. Condition 2: depression. Condition 3: anxiety. Condition 4: aggression. Condition 5: phobia. Condition 6: Paranoid. Condition 7: Schizophrenia.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Intervention group: The intervention group is trained as a group including seven sessions with topics such as: awareness, meaning-making, evaluation, focused existence, concept, visualization and mission. The duration of each training session is one hour and two sessions are held weekly. Intervention 2: Control group: Control group: This group does not receive any  intervention.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Only part of the data related to the main outcome can be shared.

When:
The start of the access period will be up to 6 months after the publication of the results.

To whom:
All interested researchers.

Conditions:
Using the data to write an article is not allowed.

Where to obtain:
In the published article, the necessary information to contact the research team will be given.

How to obtain:
Contact the responsible person and mention the reason for requesting information
The time to send the data will be between 4 and 6 weeks depending on the requested items.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Nasrin Sharifi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of nursing and midwifery; Namazi square; Shiraz</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>71936-13119</zip>
        <telephone>+98 71 1647 4254</telephone>
        <email>sharifin@sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Nasrin Sharifi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nursing and Midwifery; Namazi Square; Shiraz -</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>71936-13119</zip>
        <telephone>0098 71 36474254-8</telephone>
        <email>sharifin@sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>People who are at least 60 years old and older
Having at least a high school education
Full consent to participate in the research based on the research participation certificate form</inclusion_criteria>
      <agemin>60 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Having severe psychiatric disorders according to the primary diagnosis of a psychiatrist and the diagnosis of a clinical psychologist
Patients with brain lesions and retarded
Receiving another psychological intervention at the same time
Decided to leave the group</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F42</hc_code>
      <hc_code>F32</hc_code>
      <hc_code>F41</hc_code>
      <hc_code></hc_code>
      <hc_code>F40</hc_code>
      <hc_code>F60.0</hc_code>
      <hc_code>F20</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Obsessive-compulsive disorder</hc_keyword>
      <hc_keyword>Major depressive disorder, single episode</hc_keyword>
      <hc_keyword>Other anxiety disorders</hc_keyword>
      <hc_keyword></hc_keyword>
      <hc_keyword>Phobic anxiety disorders</hc_keyword>
      <hc_keyword>Paranoid personality disorder</hc_keyword>
      <hc_keyword>Schizophrenia</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Lifestyle</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Intervention group: The intervention group is trained as a group including seven sessions with topics such as: awareness, meaning-making, evaluation, focused existence, concept, visualization and mission. The duration of each training session is one hour and two sessions are held weekly.</i_keyword>
      <i_keyword>Control group: Control group: This group does not receive any  intervention.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Mental health, in this research, mental health is the score obtained by the subjects from completing the mental health questionnaire (R-90-SCL). Timepoint: At the beginning of the study (before the start of the intervention) and two weeks after the intervention. Method of measurement: Mental Health Questionnaire (R-90-SCL).</prim_outcome>
      <prim_outcome>Depression, In this research, depression is the score that the subjects get from completing the mental health questionnaire (R-90-SCL). Timepoint: At the beginning of the study (before the start of the intervention) and two weeks after the intervention. Method of measurement: Mental Health Questionnaire (R-90-SCL).</prim_outcome>
      <prim_outcome>Anxiety, in this research, anxiety refers to the score that subjects get from completing the mental health questionnaire (R-90-SCL). Timepoint: At the beginning of the study (before the start of the intervention) and two weeks after the intervention. Method of measurement: Mental Health Questionnaire (R-90-SCL).</prim_outcome>
      <prim_outcome>Aggression, in this research, aggression refers to the score that subjects get from completing the mental health questionnaire (R-90-SCL). Timepoint: At the beginning of the study (before the start of the intervention) and two weeks after the intervention. Method of measurement: Mental Health Questionnaire (R-90-SCL).</prim_outcome>
      <prim_outcome>Paranoid thoughts, in this research, paranoid thoughts is the score that the subjects get from completing the mental health questionnaire (R-90-SCL). Timepoint: At the beginning of the study (before the start of the intervention) and two weeks after the intervention. Method of measurement: Mental Health Questionnaire (R-90-SCL).</prim_outcome>
      <prim_outcome>In this research, the meaning of sensitivity in mutual relations is the score that subjects get from completing the mental health questionnaire (R-90-SCL). Timepoint: At the beginning of the study (before the start of the intervention) and two weeks after the intervention. Method of measurement: Mental Health Questionnaire (R-90-SCL).</prim_outcome>
      <prim_outcome>Morbid fear: In this research, morbid fear is the score obtained by subjects from completing the mental health questionnaire (R-90-SCL). Timepoint: At the beginning of the study (before the start of the intervention) and two weeks after the intervention. Method of measurement: Mental Health Questionnaire (R-90-SCL).</prim_outcome>
      <prim_outcome>Psychosis, in this research, psychosis is the score obtained by subjects from completing the mental health questionnaire (R-90-SCL). Timepoint: At the beginning of the study (before the start of the intervention) and two weeks after the intervention. Method of measurement: Mental Health Questionnaire (R-90-SCL).</prim_outcome>
      <prim_outcome>Obsessive-compulsive disorder, in this research obsessive-compulsive disorder is the score that subjects get from completing the mental health questionnaire (R-90-SCL). Timepoint: At the beginning of the study (before the start of the intervention) and two weeks after the intervention. Method of measurement: Mental Health Questionnaire (R-90-SCL).</prim_outcome>
      <prim_outcome>Physical complaints In this research, physical complaints are the scores that subjects get from completing the mental health questionnaire (R-90-SCL). Timepoint: At the beginning of the study (before the start of the intervention) and two weeks after the intervention. Method of measurement: Mental Health Questionnaire (R-90-SCL).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-04-30</approval_date>
        <contact_name>Faculties of nursing and midwifery, management and medical information, Shiraz University of Medical</contact_name>
        <contact_address>Zand Street, in front of Palestine Street, central building of Shiraz University of Medical Sciences shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
